Evidence map›Paper›PMID 37450205›Full record

ArticleJournal of natural medicines2023

Application of the relative molar sensitivity method using GC-FID to quantify safranal in saffron (Crocus sativus L.).

Naoko Masumoto, Takumi Ohno, Toshihiro Suzuki, Tadayasu Togawa, Naoki Sugimoto

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of natural medicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Naoko MasumotoDivision of Food Additives, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-Ku, Kawasaki, Kanagawa, 210-9501, Japan. nasato@nihs.go.jp.ORCID http://orcid.org/0000-0002-8987-7620
Takumi OhnoMeiji Pharmaceutical University, 2-522-1 Noshio, Kiyose-Shi, Tokyo, 204-8588, Japan.
Toshihiro SuzukiMeiji Pharmaceutical University, 2-522-1 Noshio, Kiyose-Shi, Tokyo, 204-8588, Japan.
Tadayasu TogawaMeiji Pharmaceutical University, 2-522-1 Noshio, Kiyose-Shi, Tokyo, 204-8588, Japan.
Naoki SugimotoDivision of Food Additives, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-Ku, Kawasaki, Kanagawa, 210-9501, Japan.
Meiji Pharmaceutical University · JPNational Institute of Health Sciences · JP

Funding

Japan Society for the Promotion of Science 21K20735Ministry of Health, Labour and Welfare 23KA1012
6 · The paper itself

Abstract

Safranal is one flavor component of saffron, which is used as a spice, food additive, and crude drug. In ISO3632, safranal is defined as the compound that contributes to the quality of saffron, and many quantitative determination methods for safranal have been reported. However, safranal is volatile and degrades easily during storage, and an analytical standard with an exact known purity is not commercially available, making it difficult to quantify accurately the content of safranal in saffron. Here, we developed a method for quantifying safranal using relative molar sensitivity (RMS), called the RMS method, using a GC-flame ionization detector (GC-FID). We determined the RMS of safranal to 1,4-bis(trimethylsilyl)benzene-d

Indexed as

CrocusCyclohexenesFlame IonizationPlant ExtractsReproducibility of ResultsTerpenesCyclohexenesPlant ExtractssafranalTerpenes1H-quantitative NMRCrocus sativusGC-FIDRelative molar sensitivitySaffronSafranal

Identifiers

PMID37450205
OpenAlexW4384342981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.